Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.875
-0.015 (-0.79%)
At close: Apr 28, 2026, 4:00 PM EDT
1.850
-0.025 (-1.33%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Annovis Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 4.48 | 6.7 | 6.24 | 9 | 6.06 | |
| Research & Development | 25.22 | 20 | 38.79 | 16.52 | 8.48 | |
| Operating Expenses | 29.7 | 26.69 | 45.04 | 25.51 | 14.54 | |
| Operating Income | -29.7 | -26.69 | -45.04 | -25.51 | -14.54 | |
| Interest & Investment Income | 0.7 | 0.33 | 0.67 | 0.18 | 0.01 | |
| Other Non Operating Income (Expenses) | 0.14 | 1.77 | -11.84 | - | 0.04 | |
| Pretax Income | -28.85 | -24.59 | -56.2 | -25.33 | -14.49 | |
| Net Income | -28.85 | -24.59 | -56.2 | -25.33 | -14.49 | |
| Net Income to Common | -28.85 | -24.59 | -56.2 | -25.33 | -14.49 | |
| Shares Outstanding (Basic) | 21 | 12 | 9 | 8 | 8 | |
| Shares Outstanding (Diluted) | 21 | 12 | 9 | 8 | 8 | |
| Shares Change (YoY) | 67.97% | 35.60% | 10.55% | 7.03% | 20.88% | |
| EPS (Basic) | -1.40 | -2.02 | -6.23 | -3.10 | -1.90 | |
| EPS (Diluted) | -1.40 | -2.31 | -6.23 | -3.10 | -1.90 | |
| EBIT | -29.7 | -26.69 | -45.04 | -25.51 | -14.54 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.